USANA Health Sciences (NYSE:USNA) Reaches New 1-Year Low - Should You Sell?

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $25.26 and last traded at $25.53, with a volume of 187683 shares changing hands. The stock had previously closed at $27.15.

Analyst Ratings Changes

USNA has been the topic of several recent analyst reports. StockNews.com cut shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. DA Davidson dropped their price target on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating on the stock in a research note on Thursday, February 27th. Finally, Sidoti downgraded USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a report on Tuesday, February 18th.

USANA Health Sciences Stock Performance

The company has a fifty day moving average of $30.18 and a two-hundred day moving average of $34.51. The firm has a market capitalization of $460.36 million, a price-to-earnings ratio of 8.59, a PEG ratio of 0.93 and a beta of 1.00.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating analysts' consensus estimates of $0.49 by $0.15. The firm had revenue of $213.61 million during the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. Equities analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Remove Ads

Insider Transactions at USANA Health Sciences

In other news, insider Joshua Foukas sold 5,732 shares of USANA Health Sciences stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total transaction of $186,519.28. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider David Mulham Mulham sold 3,234 shares of the company's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $32.98, for a total value of $106,657.32. Following the completion of the transaction, the insider now directly owns 12,775 shares of the company's stock, valued at $421,319.50. This represents a 20.20 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,920 shares of company stock valued at $500,285. Company insiders own 0.33% of the company's stock.

Institutional Investors Weigh In On USANA Health Sciences

Hedge funds have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP grew its position in shares of USANA Health Sciences by 7.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock valued at $27,751,000 after buying an additional 55,059 shares during the last quarter. Pacer Advisors Inc. boosted its holdings in USANA Health Sciences by 8.8% in the fourth quarter. Pacer Advisors Inc. now owns 592,001 shares of the company's stock valued at $21,247,000 after acquiring an additional 47,745 shares during the last quarter. Pzena Investment Management LLC increased its position in USANA Health Sciences by 3.6% during the 4th quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company's stock valued at $39,015,000 after purchasing an additional 37,466 shares during the period. Jane Street Group LLC raised its holdings in USANA Health Sciences by 330.0% during the 4th quarter. Jane Street Group LLC now owns 39,979 shares of the company's stock worth $1,435,000 after purchasing an additional 30,681 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of USANA Health Sciences in the 4th quarter worth approximately $953,000. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.